Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDRY.L Regulatory News (SDRY)

  • There is currently no data for SDRY

Director/PDMR Shareholding

17 May 2017 15:32

RNS Number : 4572F
SuperGroup PLC
17 May 2017
Β 

SuperGroup Plc

("SuperGroup" or the "Company")

Β 

Β 

17 May 2017

Β 

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMR") and persons closely associated with them ("PCA")

Β 

On 15 May 2017, the following transactions by PDMRs took place in relation to the SuperGroup Share Incentive Plan ("SIP"). The SIP is an all-employee trust arrangement approved by HM Revenue and Customs, under which employees are able to buy shares in the Company of 5 pence each ("Ordinary Shares"), using deductions from salary in each calendar month ("Partnership Shares"), and receive allocations of matching free Ordinary Shares ("Matching Shares").

Β 

Details of the number of Partnership Shares purchased by the PDMRs at a price of Β£16.02 per Ordinary Share, and the number of Matching Shares allocated by the SIP Trustees to the PDMRs for no consideration, are set out against their names in the table below.

Β 

Name / Position of PDMR

Number of Partnership Shares

Number of Matching shares

Hugo Adams - Group Marketing and Business Development Director

10

1

Andrea Cartwright - Group HR Director

9

1

Euan Sutherland - Chief Executive Officer

9

1

Jon Wragg - Global Trading Director

9

1

Β 

The transactions were notified to the Company by the PDMRs on 16 May 2017.

Β 

This announcement, including the notification(s) below, is made in accordance with the requirements of the EU Market Abuse Regulation.

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

1. Hugo Adams

2. Andrea Cartwright

3. Euan Sutherland

4. Jon Wragg

Β 

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

1. Group Marketing and Business Development Director/PDMR

2. Group HR Director/PDMR

3. Chief Executive Officer/PDMR

4. Global Trading Director/PDMR

b)

Β 

Initial notification /Amendment

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

SuperGroup Plc

b)

Β 

LEI

Β 

213800GAQMT2WL7BW361

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary shares of 5 pence each

Β 

Β 

Β 

ISIN: GB00B60BD277

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase and allocation of Partnership and Matching Shares (no consideration), respectively, under the SuperGroup Share Incentive Plan.

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£16.02 + nil

Β£16.02 + nil

Β£16.02 + nil

Β£16.02 + nil

Β 

1. 10 + 1

2. 9 + 1

3. 9 + 1

4. 9 + 1

Β 

d)

Β 

Aggregated information

Β 

Β 

Price(s)

Β 

Aggregated volume (s)

1. Β£160.20

2. Β£144.18

3. Β£144.18

4. Β£144.18

Β 

1. 11

2. 10

3. 10

4. 10

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

15 May 2017

f)

Β 

Place of the transaction

Β 

London Stock Exchange (XLON)

Β 

Enquiries:

Β 

SuperGroup Plc

Vanessa Lewis Camacho

+44 (0) 7825 912980

Deputy Company Secretary

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DSHARMITMBJBBMR
Date   Source Headline
28th Aug 20203:00 pmRNSTotal Voting Rights
25th Aug 202012:02 pmRNSPrice Monitoring Extension
14th Aug 202011:00 amRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSStatement re : New financing facility and trading
31st Jul 202011:00 amRNSTotal Voting Rights
24th Jul 20204:41 pmRNSSecond Price Monitoring Extn
24th Jul 20204:36 pmRNSPrice Monitoring Extension
23rd Jul 20209:34 amRNSHolding(s) in Company
21st Jul 202011:38 amRNSHolding(s) in Company
21st Jul 202011:29 amRNSHolding(s) in Company
20th Jul 20202:12 pmRNSHolding(s) in Company
14th Jul 202010:03 amRNSDirector/PDMR Shareholding
2nd Jul 202010:34 amRNSHolding(s) in Company
2nd Jul 202010:23 amRNSHolding(s) in Company
2nd Jul 20209:47 amRNSHolding(s) in Company
30th Jun 202010:21 amRNSTotal Voting Rights
29th Jun 20209:20 amRNSHolding(s) in Company
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
18th Jun 20207:00 amRNSStatement re China Joint Venture
16th Jun 20209:14 amRNSDirector/PDMR Shareholding
2nd Jun 202011:29 amRNSHolding(s) in Company
29th May 202012:02 pmRNSPrice Monitoring Extension
29th May 20209:28 amRNSTotal Voting Rights
26th May 202012:02 pmRNSPrice Monitoring Extension
22nd May 20204:15 pmRNSHolding(s) in Company
15th May 20204:41 pmRNSSecond Price Monitoring Extn
15th May 20204:36 pmRNSPrice Monitoring Extension
14th May 20209:48 amRNSDirector/PDMR Shareholding
12th May 202012:02 pmRNSPrice Monitoring Extension
7th May 20207:00 amRNSTrading Statement
30th Apr 20202:00 pmRNSTotal Voting Rights
22nd Apr 202012:07 pmRNSSecond Price Monitoring Extn
22nd Apr 202012:02 pmRNSPrice Monitoring Extension
15th Apr 20202:15 pmRNSDirector/PDMR Shareholding
9th Apr 20209:00 amRNSDirector Declaration
3rd Apr 20209:04 amRNSHolding(s) in Company
31st Mar 202011:28 amRNSTotal Voting Rights
31st Mar 202010:46 amRNSHolding(s) in Company
27th Mar 20204:37 pmRNSPrice Monitoring Extension
26th Mar 202012:02 pmRNSPrice Monitoring Extension
25th Mar 20204:42 pmRNSSecond Price Monitoring Extn
25th Mar 20204:37 pmRNSPrice Monitoring Extension
24th Mar 202010:15 amRNSHolding(s) in Company
23rd Mar 20202:34 pmRNSBlock listing Interim Review
18th Mar 20207:00 amRNSStatement re Current trading and COVID-19 update
16th Mar 202010:42 amRNSDirector/PDMR Shareholding
4th Mar 20209:21 amRNSHolding(s) in Company
2nd Mar 20204:17 pmRNSHolding(s) in Company
28th Feb 20208:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.